NCT03030937 2017-01-25
Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA
Fujian Cancer Hospital
Phase 2 Unknown
Clinical Trials
1 trialsPhase 2 × Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction × Gastrointestinal × Clear all